Correlation Between Annovis Bio and Moderna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Annovis Bio and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annovis Bio and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annovis Bio and Moderna, you can compare the effects of market volatilities on Annovis Bio and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annovis Bio with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annovis Bio and Moderna.

Diversification Opportunities for Annovis Bio and Moderna

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Annovis and Moderna is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Annovis Bio and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Annovis Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annovis Bio are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Annovis Bio i.e., Annovis Bio and Moderna go up and down completely randomly.

Pair Corralation between Annovis Bio and Moderna

Given the investment horizon of 90 days Annovis Bio is expected to under-perform the Moderna. But the stock apears to be less risky and, when comparing its historical volatility, Annovis Bio is 1.66 times less risky than Moderna. The stock trades about -0.32 of its potential returns per unit of risk. The Moderna is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  17,526  in Moderna on May 10, 2022 and sell it today you would earn a total of  1,002  from holding Moderna or generate 5.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Annovis Bio  vs.  Moderna

 Performance (%) 
       Timeline  
Annovis Bio 
Annovis Performance
5 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Annovis Bio are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Annovis Bio reported solid returns over the last few months and may actually be approaching a breakup point.

Annovis Price Channel

Moderna 
Moderna Performance
10 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Moderna are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Moderna sustained solid returns over the last few months and may actually be approaching a breakup point.

Moderna Price Channel

Annovis Bio and Moderna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Annovis Bio and Moderna

The main advantage of trading using opposite Annovis Bio and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annovis Bio position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.

Annovis Bio

Pair trading matchups for Annovis Bio

The idea behind Annovis Bio and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Moderna

Pair trading matchups for Moderna

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go